These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1301743)

  • 1. Blood substitutes: engineering the haemoglobin molecule.
    Vandegriff KD
    Biotechnol Genet Eng Rev; 1992; 10():403-53. PubMed ID: 1301743
    [No Abstract]   [Full Text] [Related]  

  • 2. Allosteric regulation of crocodilian haemoglobin.
    Perutz MF; Bauer C; Gros G; Leclercq F; Vandecasserie C; Schnek AG; Braunitzer G; Friday AE; Joysey KA
    Nature; 1981 Jun; 291(5817):682-4. PubMed ID: 7242674
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant haemoglobin in the development of red-blood-cell substitutes.
    Ogden JE
    Trends Biotechnol; 1992 Mar; 10(3):91-6. PubMed ID: 1367945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin-based oxygen carriers as blood substitutes.
    Mozzarelli A
    Biochim Biophys Acta; 2008 Oct; 1784(10):1363-4. PubMed ID: 18809148
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular code for cooperativity in hemoglobin.
    Ackers GK; Doyle ML; Myers D; Daugherty MA
    Science; 1992 Jan; 255(5040):54-63. PubMed ID: 1553532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereochemistry of cooperative mechanisms in hemoglobin.
    Perutz MF; Fermi G; Luisi B; Shaanan B; Liddington RC
    Cold Spring Harb Symp Quant Biol; 1987; 52():555-65. PubMed ID: 3454276
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of polycondensed hemoglobin as the basis of a blood substitute capable of transporting oxygen.
    Kuznetsova NP; Gudkin LR; Mishaeva RN; Panarin EF; Bystrova IM; Selivanov EA
    Dokl Biochem Biophys; 2002; 386():257-9. PubMed ID: 12469503
    [No Abstract]   [Full Text] [Related]  

  • 8. Examples of chemical modification and recombinant DNA approaches with hemoglobin.
    Manning JM
    Transfus Clin Biol; 1996; 3(2):109-11. PubMed ID: 8792558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular engineering of hemoglobin for transfusion].
    Poyart C; Baudin V; Pagnier J
    Rev Fr Transfus Hemobiol; 1992 Dec; 35(6):417-24. PubMed ID: 1288540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bis-pyridoxal polyphosphates: a new class of specific intramolecular crosslinking agents for hemoglobin.
    Benesch RE; Kwong S
    Biochem Biophys Res Commun; 1988 Oct; 156(1):9-14. PubMed ID: 3178853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hb(alphaalpha,betabeta): a novel fusion construct for a dimeric, four-domain hemoglobin.
    Panetta G; Arcovito A; Morea V; Bellelli A; Miele AE
    Biochim Biophys Acta; 2008 Oct; 1784(10):1462-70. PubMed ID: 18267132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin engineering. For fun and money.
    Brunori M; Cutruzzolà F; Vallone B
    Curr Biol; 1995 May; 5(5):462-5. PubMed ID: 7583088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hemoglobins as artificial oxygen carriers.
    Fronticelli C; Koehler RC; Brinigar WS
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):45-52. PubMed ID: 17364470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of chemically cross-linked hemoglobin solutions designed as temporary oxygen carriers.
    Keipert PE
    Adv Exp Med Biol; 1992; 317():453-64. PubMed ID: 1288157
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of hemoglobin as a blood substitute.
    Bunn HF
    Am J Hematol; 1993 Jan; 42(1):112-7. PubMed ID: 8416284
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancing stability and expression of recombinant human hemoglobin in E. coli: Progress in the development of a recombinant HBOC source.
    Graves PE; Henderson DP; Horstman MJ; Solomon BJ; Olson JS
    Biochim Biophys Acta; 2008 Oct; 1784(10):1471-9. PubMed ID: 18489914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
    Alayash AI; D'Agnillo F; Buehler PW
    Expert Opin Biol Ther; 2007 May; 7(5):665-75. PubMed ID: 17477804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathway of allosteric control as revealed by hemoglobin intermediate states.
    Holt JM; Ackers GK
    FASEB J; 1995 Feb; 9(2):210-8. PubMed ID: 7781923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human recombinant haemoglobin designed for use as a blood substitute.
    Looker D; Abbott-Brown D; Cozart P; Durfee S; Hoffman S; Mathews AJ; Miller-Roehrich J; Shoemaker S; Trimble S; Fermi G
    Nature; 1992 Mar; 356(6366):258-60. PubMed ID: 1552945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering and design of blood substitutes.
    Sanders KE; Ackers G; Sligar S
    Curr Opin Struct Biol; 1996 Aug; 6(4):534-40. PubMed ID: 8794165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.